<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hussain I</submitter><funding>Bill and Melinda Gates Foundation</funding><pagination>31</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12852092</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>Wild poliovirus remains endemic in Pakistan and Afghanistan despite global progress. We quantified immunity to poliovirus types 1-3 among children aged 6-23 months in 44 high-risk districts (2022-2023) using a cross-sectional serosurvey with probability proportional to size (PPS) cluster sampling. We enrolled 20,680 children (10,112 aged 6-11 months; 10,568 aged 12-23 months). Seroprevalence among 6-11-month-olds was 94.5% (type 1), 44.6% (type 2), and 88.0% (type 3); among 12-23-month-olds, it was 95.9%, 53.8%, and 91.2%, respectively. Type 1 seropositivity was highest across provinces; type 3 exceeded 90% except in Balochistan and KP; type 2 was lowest everywhere. Younger children have lower immunity. In multivariable models, residence in Balochistan predicted reduced seroprotection (AOR</pubmed_abstract><journal>NPJ vaccines</journal><pubmed_title>Progress and gaps in poliovirus immunity: Evidence from a serological survey of children aged 6-23 months in high-risk districts of Pakistan.</pubmed_title><pmcid>PMC12852092</pmcid><funding_grant_id>OPP1156736</funding_grant_id><pubmed_authors>Alam MM</pubmed_authors><pubmed_authors>Partridge J</pubmed_authors><pubmed_authors>Soofi S</pubmed_authors><pubmed_authors>Bosan A</pubmed_authors><pubmed_authors>Hafiz R</pubmed_authors><pubmed_authors>Sajid M</pubmed_authors><pubmed_authors>Hussain I</pubmed_authors><pubmed_authors>Khan A</pubmed_authors><pubmed_authors>Umer M</pubmed_authors><pubmed_authors>Abbas H</pubmed_authors><pubmed_authors>Haq MA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Progress and gaps in poliovirus immunity: Evidence from a serological survey of children aged 6-23 months in high-risk districts of Pakistan.</name><description>Wild poliovirus remains endemic in Pakistan and Afghanistan despite global progress. We quantified immunity to poliovirus types 1-3 among children aged 6-23 months in 44 high-risk districts (2022-2023) using a cross-sectional serosurvey with probability proportional to size (PPS) cluster sampling. We enrolled 20,680 children (10,112 aged 6-11 months; 10,568 aged 12-23 months). Seroprevalence among 6-11-month-olds was 94.5% (type 1), 44.6% (type 2), and 88.0% (type 3); among 12-23-month-olds, it was 95.9%, 53.8%, and 91.2%, respectively. Type 1 seropositivity was highest across provinces; type 3 exceeded 90% except in Balochistan and KP; type 2 was lowest everywhere. Younger children have lower immunity. In multivariable models, residence in Balochistan predicted reduced seroprotection (AOR</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-12T10:19:04.993Z</modification><creation>2026-06-12T03:11:39.73Z</creation></dates><accession>S-EPMC12852092</accession><cross_references><pubmed>41469400</pubmed><doi>10.1038/s41541-025-01352-1</doi></cross_references></HashMap>